StockGlow

Neurocrine Biosciences, Inc. (NB3.F)

Neurocrine Biosciences, Inc.

160.50+0.02%Healthcare
Compare NB3.F with
StockGlow Score
97
Bullish
BearishBullish
1 year ago+44.2%

The outlook

Neurocrine Biosciences, Inc. currently reads as bullish based on above its 50- & 200-day averages, 100% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$16.14B
52-wk high
160.50
52-wk low
102.55
50-day avg
144.08
200-day avg
124.63
Trailing P/E
28.2

Similar stocks

VX1.FVertex Pharmaceuticals Incorporated$414.30+0.74%ICY.FIncyte Corporation$107.20-2.85%AB3A.FSarepta Therapeutics, Inc.$13.62+0.89%RV7.FHalozyme Therapeutics, Inc.$72.16-0.39%DUL.FAlnylam Pharmaceuticals, Inc.$180.00+1.01%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy